Solutions to PBM Pricing Abuses Must Address Entire Drug Supply Chain

SCPC Tells HELP Committee “A comprehensive full-spectrum solution is the only real option”…Read More.

SCPC Praises Final FDA Repackaging Guidance Recognizing LTC Pharmacies’ Unique Value in U.S. Health Care Continuum

Senior Care Pharmacy Coalition (SCPC) Lauds Elimination of 14-Day Pre-Packaging Guideline, Proceeding with Additional Analysis of LTC Pharmacy Issues  Washington, DC – Following an initial analysis, the Senior Care Pharmacy Coalition (SCPC) today praised the Food and Drug Administration’s (FDA’s) final regulatory guidance regarding the “Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing read more…

Pharmacy owner: There’s a huge issue with PBMs

Brad Arthur, Black Rock Pharmacy co-owner, shares his take on the rising drug prices and the pharma supply chain…Read More

Filling A Prescription? You Might Be Better Off Paying Cash

Kaiser Health News
Pharmacists say large pharmacy benefit management (PBM) firms that handle benefit claims for millions of Americans are pocketing the difference, while those firms say pharmacists themselves are being greedy…Read More

House Members Want Greater Transparency on Drugs Reimbursement

Morning Consult
Sixteen House members are asking three pairs of committee leaders to consider a bill they say would improve transparency of the business partnerships between the government and pharmacy benefit managers…Read More

Comment Letter on CMS Medicare & Medicaid Conditions of Participation for LTC Facilities Proposed Rule

The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to address the Center for Medicare and Medicaid Services (“CMS”) “Medicare and Medicaid Conditions of Participation for Long Term Care Facilities” Proposed Rule, 80 Fed. Reg. 42168 (July 16, 2015) (the “Proposed Rule”1). The SCPC is the national association representing independent long term care (“LTC”) pharmacies. read more…

CMS Call Letter: Pharmacy Network Implications

The National Law Review
As part of our continuing series on CMS’s 2016 Call Letter, we take a closer look at the provisions in the Call Letter affecting PBM and plan sponsor pharmacy networks…Read More

Impact of Value-Based Payment Models on Pharmacies

Pharmacy Times
Pharmacies can anticipate new, specific goals that tie fee-for-service Medicare payments to value-based payment models, according to the US Department of Health and Human Services (HHS)….Read More

FDA Pressed on Generic Drug Labeling Rule

CQ Roll Call
A consumer advocacy group is warning the Food and Drug Administration that industry pressure to delay a generic drug labeling rule could damage patient safety….Read More

Medicare’s Drug Substitution Policy Saved $13 Million From 2013-2014, OIG Says

Bloomberg BNA
The Centers for Medicare & Medicaid Services’ drug price substitution policy saved Medicare and its beneficiaries an estimated $13 million from the fourth quarter of 2013 through the third quarter of 2014….Read More

Twitter   LinkedIn